Skip to main content
SingaporeGeneral PaperSyllabus dot point

How far should we go in using genetic engineering and biotechnology to alter living things, including ourselves?

Evaluate the promise and the ethical limits of genetic engineering and biotechnology in medicine, food and human enhancement

A focused answer to the General Paper theme of genetic engineering. Balanced arguments on gene editing, GM food and human enhancement, the ethical limits and the playing-God objection, with examples for any related question.

Generated by Claude Opus 4.810 min answer

Reviewed by: AI editorial process; not yet individually human-reviewed

Have a quick question? Jump to the Q&A page

Jump to a section
  1. What this dot point is asking
  2. The answer
  3. Examples in context
  4. Try this

What this dot point is asking

This theme gives you balanced material for General Paper questions on genetic engineering and biotechnology: gene editing in medicine, genetically modified food, and the prospect of human enhancement. The central insight is that the question is almost never "should we use this technology at all" but "where should we draw the line", because the same tools that cure disease can also raise serious ethical concerns. A strong answer separates the clear benefits from the contested uses, handles the "playing God" objection fairly, and argues for principled limits.

The answer

The promise

Biotechnology offers benefits that an essay should state precisely:

  • Curing disease. Gene therapy and tools such as CRISPR offer the prospect of treating or curing inherited disorders at their genetic root.
  • Food security. Genetically modified crops can raise yields and add drought resistance, pest resistance and nutrition, helping feed a growing population on limited land.
  • Industrial and medical production. Engineered organisms produce medicines, including insulin, and sustainable industrial inputs.

The ethical limits

Against the promise sit real concerns:

  • Safety and unintended consequences. Edits can have unforeseen effects, and some are irreversible, especially heritable ones.
  • Therapy versus enhancement. Curing disease is widely accepted; designing desirable traits (intelligence, appearance) is far more contested.
  • Equity. If enhancement is available only to the wealthy, it could entrench a new biological inequality.
  • Consent. Heritable edits affect future generations who cannot consent.
  • Ecology. Engineered organisms released into ecosystems carry biodiversity risks.

The therapy-enhancement line

The single most useful distinction in this theme is between therapy (restoring normal function, curing disease) and enhancement (improving traits beyond the normal). Most ethical frameworks accept therapy more readily than enhancement, because therapy relieves suffering while enhancement raises questions of fairness, consent and what we value in being human. Drawing answers around this line lets you support beneficial uses while opposing troubling ones, the essence of a balanced judgement.

The "playing God" objection

Questions in this theme often invoke the idea that we should not "play God" or interfere with nature. Handle it fairly: it expresses a genuine caution about hubris, humility and irreversibility, which deserves respect. But it proves too much if taken literally, since medicine, agriculture and vaccination already "interfere with nature" to great benefit. The mature position treats it not as a veto but as a reason for caution and limits, especially where consequences are irreversible.

Examples in context

Example 1. Gene editing for inherited disease. The use of gene-editing tools to treat conditions such as sickle-cell disease, by correcting the genetic fault in a patient's own cells, exemplifies the therapy end of the spectrum: a clear medical benefit, relieving real suffering, with risks that can be assessed and managed in a regulated clinical setting. It is the strongest evidence for supporting beneficial uses, and contrasts sharply with the far more contested prospect of editing embryos to enhance traits, illustrating exactly where the ethical line falls.

Example 2. Singapore's food security and novel foods. Importing most of its food and pursuing a goal to produce a substantial share of its nutritional needs locally, Singapore has supported biotechnology including cultivated and novel foods and was an early approver of cultured meat. This shows how a land-scarce society weighs biotechnology's promise against caution: the tools are embraced where they address a genuine national need and are carefully regulated, evidencing the conditional, governance-focused judgement a balanced essay should reach.

Try this

Q1. Explain the difference between gene therapy and genetic enhancement. [2 marks]

  • Cue. Therapy restores normal function or cures disease (correcting a faulty gene), while enhancement improves traits beyond the normal (such as intelligence or appearance), which raises sharper questions of fairness and consent.

Q2. Give one reason heritable genetic edits raise a consent problem. [2 marks]

  • Cue. They alter the genome of future generations who cannot consent to the change, and any unforeseen harmful effects would be passed on irreversibly.

Q3. Explain why the "playing God" objection is not a complete answer to genetic engineering. [3 marks]

  • Cue. It rightly warns against hubris and irreversibility, but proves too much if taken literally, because medicine, agriculture and vaccination already intervene in nature to great benefit, so it works as a reason for caution and limits rather than as a blanket veto.

Exam-style practice questions

Practice questions written in the style of SEAB exam questions on this dot point, with worked answer explainers. The year tag is the paper they imitate, not the source.

Original12 marks'Just because we can genetically engineer life does not mean we should.' Discuss.
Show worked answer →

Stand: a qualified agreement. Capability does not justify use, so limits are needed; but a blanket refusal would forgo enormous benefits, so the issue is where to draw the line, not whether to use the technology at all.

The promise to develop: curing genetic disease (gene therapy, CRISPR); more resilient and nutritious crops to feed a growing population; medicines and industrial processes from engineered organisms.

The ethical limits: safety and unintended consequences; the distinction between therapy (curing disease) and enhancement (designing traits); equity, if enhancement is available only to the wealthy; consent for future generations in heritable edits; and ecological risk for engineered organisms.

The 'playing God' objection: assess it fairly - it expresses a real caution about hubris and irreversibility, but proves too much if taken to ban all intervention in nature, since medicine already intervenes.

Judgement: we should use the technology where benefits are clear and risks managed (therapy, disease-resistant crops) but draw firm lines at unsafe, inequitable or non-consensual uses (heritable enhancement), so 'can' does not equal 'should' without ethical limits. Markers reward the therapy-enhancement distinction, fair handling of the playing-God objection, and a line-drawing judgement.

Original12 marksTo what extent should genetically modified food be embraced?
Show worked answer →

Stand: GM food should be embraced to a significant but conditional extent - where it is safe, well-regulated and addresses real needs - rather than rejected outright or accepted uncritically.

The case for: higher yields, drought and pest resistance, and enhanced nutrition can improve food security for a growing population on limited land; scientific consensus generally supports the safety of approved GM crops.

The case for caution: concerns about corporate control of seeds and farmers' dependence; ecological effects and biodiversity; long-term and consumer-choice questions; and unequal distribution of benefits.

Reframe: the strongest objections are often about governance (who controls the technology, how it is regulated and labelled) rather than the science itself.

Local grounding: Singapore, importing most of its food and pursuing a '30 by 30' food-security goal, has interest in biotechnology including novel and cultivated foods, illustrating how a land-scarce society weighs these tools.

Judgement: embrace GM food where safe and well-governed, with regulation, labelling and attention to equity, so the answer is a conditional yes. Markers reward distinguishing science from governance, balance, and a conditional judgement.

Related dot points